The innovative new MCD Platform represents a new approach to assay processing and
results analysis. The multiplexed assay has individual target molecules spotted
directly into microwells. MCD operates to ISO 13485, our staff are experienced
in FDA 510k applications and we maintain all documentation to enable our collaborators
to obtain CE markeing or FDA clearance. MCD is well equipped to carry out design
work, or to use target molecules provided by a 3rd party for use on this system.